Sotio partners with Merck to test lead candidate with Keytruda; DC's KeifeRx raises $6M in Series A — and brings on two new board members
Sotio has been on a roll lately.
The quiet Czech biotech based in Prague got a massive $315 million raise last week, and now the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
